A novel triple-action oral care technology combining L-Arginine, Xylo-oligosaccharides, and Lactobacillus ferment lysate to enhance gingival health by neutralizing acidic environments, inhibiting pathogen adhesion, and modulating inflammation.
This innovative solution offers a comprehensive approach to oral care by utilizing a synergy of L-Arginine, Xylo-oligosaccharides (XOS), and a Lactobacillus ferment lysate. Together, these components work to maintain gingival homeostasis through a triple-action mechanism. The technology targets the ecological drivers of gingival dysbiosis, promoting beneficial commensals that reverse low-pH environments, inhibiting pathogen adhesion, and modulating inflammatory responses, thus maintaining a healthy oral microbiome.
Key features:
The technology effectively balances oral ecology with a shelf-stable formulation, suitable for incorporation into consumer oral care products like mouthwash.
Currently at TRL 4, this technology has demonstrated potential in laboratory settings with ongoing plans for further validation through sponsored research. The next phase includes formulating a synbiotic mouthwash to test efficacy and stability, ensuring the active ingredients remain effective and consumer-friendly.